𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quality of life and sexual function after palladium 103 prostate brachytherapy

✍ Scribed by A. Losa; L. Nava; T. Maga; L. Rigatti; M. Riva; M. Zanoni; P. Mangili; N. Di Muzio; G. Guazzoni; P. Rigatti

Book ID
118643549
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
163 KB
Volume
1
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Short-term sexual function after prostat
Short-term sexual function after prostate brachytherapy
✍ Gregory S. Merrick; Kent Wallner; Wayne M. Butler; Jonathan H. Lief; Steven Sutl πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 346 KB

## Abstract Sexual function was evaluated in 34 patients with low‐risk prostate cancer (PSA ≀ 10, Gleason score ≀ 6, clinical stage T1/T2) undergoing brachytherapy in a phase III prospective randomized trial comparing iodine‐125 (^125^I) to palladium‐103 (^103^Pd). The mean and median International

Impact of a novel neoadjuvant and adjuva
Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapy
✍ Nicole L. Miller; Eric A. Bissonette; Robert Bahnson; John Wilson; Dan Theodores πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 127 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Data demonstrate a benefit from neoadjuvant and adjuvant hormone‐deprivation therapy with luteinizing hormone‐releasing hormone agonists in patients who are treated with radiotherapy for localized prostate carcinoma; however, this approach has detrimental effects on quali